Updated Jul 10, 2020
Christine Kim
Send MessageIn a health crisis like the COVID-19 outbreak, ensuring that vaccines and other lifesaving medicines are reaching their beneficiaries is critical. To stop a disease spreading, you need to diagnose people rapidly and accurately, and track others who they’ve contacted. But more than 1B people globally lack legal identification, and these people are less likely to be able to access health services, less likely to know their disease status, and, ultimately, more likely to pass the disease to others.
Simprints's mission is to transform the way the world fights poverty. We build technology to radically increase transparency and effectiveness in global development, making sure that every vaccine, every dollar, every public good reaches the people who need them most. Simprints' technology ensures that health workers in the last mile are able to reach real patients, tracking cases over time and geography, and ensuring equitable delivery of vaccines and medical services in last mile settings.
Funding Goal | 1,000,000 | |
Projected Cumulative Lives Impacted | 500,000 |
Dr. Toby Norman: CEO & Co-founder Toby has worked for >10 years on initiatives to improve global health and development through technology. He is a 2018 GLG Fellow, 2017 Schwab Social Entrepreneur of the Year, and 2016 Forbes 30 Under 30 Entrepreneur. Alexandra Grigore: Chief Product Officer & Co-Founder She has a PhD in Nanoscience from the University of Cambridge. She is a 2015 Top 200 Movers & Shakers in BioTech, 2017 Women in Tech winner, and 2017 Top 50 Movers and Shakers in BioBusiness.
EXECUTIVE TEAM INCLUDES WOMEN